Symptoms like severe dizziness, fainting, confusion, or difficulty breathing could indicate a serious adverse reaction
CMS has issued guidance to Medicare Part D plans stating that anti-obesity medications that receive FDA approval for an additional medically accepted indication can be considered a Part D drug for that specific use, the spokesperson explained, adding that Medicare coverage is still not available to patients only taking the drug to lose weight
Papke RL, Stokes C, Damaj MI, Thakur GA, Manther K, Treinin M, Bagdas D, Kulkarni AR, Horenstein NA (2018) Persistent activation of 7 nicotinic ACh receptors associated with stable induction of different desensitized states
The impact on fetus during pregnancy or children during breastfeeding has not been studied to sufficient extent, hence there is a need for caution
The results of these finger pricks may still be providing limited information, however
Others worried about the potential long-term risks of GLP-1s, which could require lifelong use given that weight usually returns when treatment ends
